Additionally, studies examining intratumoral heterogeneity found that it can be maintained by interactions between tumor cells, including the up-regulation of IL-6 production in EGFRvIII cells to activate neighboring wtEGFR cells, enhancing tumor growth and resistance to therapy (7). Here, IL6 is linked to neoplasm.